Please provide your email address to receive an email when new articles are posted on . Interatrial shunt implant lowered HF hospitalization risk for patients with HFrEF vs. placebo. However, patients ...

For well-treated patients refractory to standard medications, the Ventura interatrial shunt was no better than sham in terms of primary effectiveness over nearly 2 years, defined by a hierarchical ...

Alzheimer’s research has yet to yield many useful therapies, even as the demand for treatments grows -- U.S. cases are expected to increase from 4 million to as many as 16 million by the middle of ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ATLANTA -- ...

Children born with certain heart defects undergo a series of invasive surgeries early in life. The first surgery includes implantation of a shunt to improve blood flow. However, as children grow, the ...

V-Wave has raised $98 million to complete the clinical testing of its implant for severe heart failure and pulmonary arterial hypertension, as well as set up the device for FDA review. The company’s ...

For babies born with a certain heart defect, implantation of a "shunt" is essential to their survival. A new type of shunt can be expanded using light after it's been implanted, potentially ...

Congenital heart defects (CHDs) are among the top eight causes of infant mortality worldwide. Annually, CHDs affect around 40,000 infants in the United States, with approximately one in four having a ...

DENVER, Aug. 19, 2024 — Children born with defects that impair the heart’s lower chambers undergo a series of invasive surgeries early in life. The first surgery includes implantation of a plastic ...